Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction

Journal of Sexual Medicine

Volumn 8, Issue 3, 2011, Pages 705-711

  Hotta, Yuji ^a   Hattori, Mayuko ^a   Kataoka, Tomoya ^a   Ohno, Risa ^a   Mikumo, Mayumi ^a   Maeda, Yasuhiro ^a,b   Kimura, Kazunori ^a,b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Arteriogenic; Chronic PDE5 Inhibitor Therapy; Erectile Dysfunction; Structure; Vardenafil

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; VARDENAFIL; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTERIOGENIC ERECTILE DYSFUNCTION; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG HALF LIFE; DRUG MEGADOSE; ELECTROSTIMULATION; ERECTILE DYSFUNCTION; HEMODYNAMICS; INTERNAL ILIAC ARTERY; INTRACAVERNOUS PRESSURE; LONG TERM CARE; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PENILE CORPORA CAVERNOSA; PENIS; PENIS ERECTION; PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SMOOTH MUSCLE; TREATMENT DURATION; WESTERN BLOTTING;

EID: 79951962170     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02153.x     Document Type: Article

References (24)

1. Levine FJ, Greenfield AJ, Goldstein I. Arteriographically determined occlusive disease within the hypogastric-cavernous bed in impotent patients following blunt perineal and pelvic trauma. J Urol 1990;144:1147-53.
2. Lin CS, Ho HC, Gholami S, Chen KC, Jad A, Lue TF. Gene expression profiling of an arteriogenic impotence model. Biochem Biophys Res Commun 2001;285:565-9.
3. Grein U, Schubert GE. Arteriosclerosis of penile arteries: Histological findings and their significance in the treatment of erectile dysfunction. Urol Int 2002;68:261-4.
4. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y. EAU guidelines on erectile dysfunction: An update. Eur Urol 2006;49:806-15.
5. Shindel AW. 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME). J Sex Med 2009;6:1794-808.
6. Shindel AW. 2009 update on phosphodiesterase type 5 inhibitor therapy part 2: Updates on optimal utilization for sexual concerns and rare toxicities in this class. J Sex Med 2009;6:2352-64.
7. Sommer F, Klotz T, Engelmann U. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: A randomized trial. Asian J Androl 2007;9:134-41.
8. Vardi Y, Appel B, Ofer Y, Greunwald I, Dayan L, Jacob G. Effect of Chronic sildenafil treatment on penile endothelial function: A randomized, double-blind, placebo controlled study. J Urol 2009;182:2850-5.
9. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-27.
10. Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, Takeuchi K, Iwao H, Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res 1998;38:116-24.
11. El-Sakka AI, Bakircioglu ME, Bhatnagar RS, Yen TS, Dahiya R, Lue TF. The effects of colchicine on a Peyronie's-like condition in an animal model. J Urol 1999;161:1980-3.
12. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 2003;9:229-44.
13. Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int 2006;97:625-33.
14. Yono M, Yamamoto Y, Yoshida M, Ueda S, Latifpour J. Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract. Life Sci 2007;81:218-22.
15. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin CS, Pohl J, Lue TF. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008;5:1866-75.
16. Wentzel P, Gäreskog M, Eriksson UJ. Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats. Diabetes 2008;57:3344-52.
17. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Yilmaz H, Butrous G, Ermert L, Ermert M, Weissmann N, Rose F, Guenther A, Walmrath D, Seeger W, Grimminger F. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med 2004;169:39-45.
18. Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 2005;111:1601-10.
19. Stiebellehner L, Petkov V, Vonbank K, Funk G, Schenk P, Ziesche R, Block LH. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 2003;123:1293-5.
20. Barreto AC, Franchi SM, Castro CR, Lopes AA. One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease. Braz J Med Biol Res 2005;38:185-95.
21. Knoderer CA, Ebenroth ES, Brown JW. Chronic outpatient sildenafil therapy for pulmonary hypertension in a child after cardiac surgery. Pediatr Cardiol 2005;26:859-61.
22. Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Respir Med 2005;99:1501-10.
23. Liu G, Sun X, Dai Y, Zheng F, Wang D, Huang Y, Bian J, Deng C. Chronic administration of sildenafil modified the impaired VEGF system and improved the erectile function in rats with diabetic erectile dysfunction. J Sex Med 2010 May 4 [Epub ahead of print] doi: 10.1111/j.1743-6109.2010.01844.x.
24. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000;58:2351-66.